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Objectives. The incidence and effect of bare stent struts crossing the renal ostia following endovascular aortic aneurysm
repair with the Talent stent-graft is not known. The study aims to establish the incidence in which bare stent struts cross
the renal ostia and to assess any associated effects on renal function.
Methods. Fifty-five patients (51 men, mean age 73 years, range 57e90) who had endovascular repair of their abdominal
aortic aneurysms with a Talent suprarenal stent-graft were included in the study. Patients were scanned at a variety of
follow-up periods (median 24 months, range 3e102). The relationship between the bare stent struts and the renal ostia,
together with renal function were retrospectively recorded. The presence and location of the bare stent struts was assessed
using CT virtual intravascular endoscopy (CT VIE). Struts were defined as being absent, peripherally located or in the
central channel of the renal ostia. Renal function was assessed from glomerular filtration rates (GFR) derived from serum
creatinine levels and the Cockcroft and Gault formula.
Results. A total of 109 renal ostia were evaluated by CT VIE with one patient having a previous nephrectomy. Bare stent
struts crossed 1 renal ostium in 22 (40%) patients and bilateral ostia in 5 (9%) patients. Of the 109 ostia assessed, 15
(14%) ostia were crossed centrally and 17 (16%) had struts crossing the ostium peripherally. There were no statistically
significant differences in the change between pre-operative GFR and latest GFR in the group without any strut involve-
ment (6 mLs/min 7 mLs/min) and the group with struts crossing one or both renal ostia (2 mLs/min 9mLs/min;
p> .05).
Conclusion. Peripheral or central coverage of renal ostia by bare stent struts occurs in a third of all renal arteries following
EVAR. Crossing of renal ostia by bare stent struts does not affect follow-up GFR.
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Endovascular repair is fast becoming an acceptable
and challenging alternative to open surgery for the
treatment of abdominal aortic aneurysms (AAA).
There is clear short-term survival benefit of EVAR
when compared to open repair.1,2 Despite the re-
ported advantages there is concern regarding the
long-term durability of aortic stent-grafts.1 Fabric
tears,3 stent fractures4 and graft migrations5,6 have
been reported. A large proportion of commercially
available stent-grafts used in clinical practice have
a bare suprarenal component to facilitate proximal fix-
ation. The behaviour of these stent struts crossing the
renal ostia and their effect on renal function is not well
understood.7 Assessment of the relationship between
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even with modern day radiological imaging. There
are increasing numbers of reports in the literature of
CT virtual intravascular endoscopy being used in
the assessment of the aorta and aortic stent-grafts.7e13
The aim of this study is to investigate the incidence
of bare stent struts crossing the renal ostia in patients
treated with a Talent suprarenal stent-graft (Medtronic
AVE, Santa Rosa, CA). Additionally, we also wish to
investigate the associated effect on renal function of
these bare stent struts crossing the renal ostia.
Materials and Method
Between January 2004 and January 2005 there were 82
patients in our endovascular follow-up programme.
Five patients had US/MR follow-up, four patients
repeatedly failed to attend and four patients were
lost to follow-up. Sixty nine consecutive patients
with a Talent suprarenal stent-graft attended forrved.
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The study consisted of two parts, retrospective inspec-
tion of the renal ostia for stent coverage using CT vir-
tual intravascular endoscopy (CT VIE). The second
part of the study was the retrospective comparison
of renal function in patients with and without bare
suprarenal stent struts crossing the renal ostia. Clini-
cal records, radiographic studies and laboratory data
of all patients undergoing endovascular repair with
suprarenal stent-grafts were reviewed. Follow-up
studies were conducted at discharge, 3 months and
annually thereafter. We have been performing EVAR
procedures since 1997, this study is cross-sectional
in design with patients attending at a variety of
follow-up periods (median 24, range 3e102 months).
Patient assessment included routine laboratory stud-
ies, clinical assessment and radiological imaging (du-
plex ultrasound and contrast-enhanced CT scanning).
The specific technique used to implant the Talent
stent-graft has been described in the literature.14
Informed consent for EVAR was obtained for all
patients and our local research and ethics committee
approved the study.
CT scanner and parameters
Multislice CT examinations were performed on a
Siemens Somatom Sensation 16 (Siemens, Erlangen,
Germany) 16 slice CTscanner. The detector collimation
of the scanner was set to 0.7 mm. The rotation time of
the CT scanner was set to 0.5 seconds, the tube voltage
was 120 kVp, and the current was 200 mAs. One
millimetre images were reconstructed with a 0.7 mm
reconstruction interval (Kernel 30f very soft). A topo-
gram was first obtained to define the range of the
scan, scans were take from the inferior border of the
twelfth thoracic vertebrae to the superior border of
the acetabulum. All patients received an intravenous
injection of iodinated contrast medium (iohexol
240 mgI/mL, 100 mLs at 3 mLs1, GE Healthcare,
Cork, Ireland). Data was acquired during arterial and
late (60 seconds) phases of contrast enhancement using
the in-built bolus tracking software for automatic scan
triggering. After scanning, CT data was transferred to
a workstation (Siemens Leonardo, Siemens, Erlangen,
Germany) for analysis. All data was reviewed for
clinical abnormality by a consultant vascular radiolo-
gist at the time of scanning. Only patients with an
arterial phase follow-up CT scan with a reconstructed
slice thickness of 1.0 mm were included in the study.
Patients with reconstructed slice thickness of >1.0 mm
or non-arterial phase scans were excluded as the
CT data did not facilitated examination of the renal
arteries by CT VIE. A total of fourteen patientsEur J Vasc Endovasc Surg Vol 32, November 2006were excluded from the study as a result of viola-
tions to the scanning protocol (alternative scanned
used, scanned as part of another imaging protocol,
single non-arterial phase acquisition).
CT virtual intravascular endoscopy
Following acquisition all CT data for each patient was
loaded onto the Siemens Leonardo workstation for
fly-through analysis. All images were loaded into
the MPR mode, where they were reconstructed into
orthogonal planes (transaxial, coronal and sagittal).
The upper limit for the endoscopic navigator system
was set at 100 Housfield units, and the lower thresh-
old at the lowest level possible (1024). This allowed
subtraction of the endoluminal contrast from the aorta
and renal arteries. The data obtained was displayed as
volume rendered intraluminal images. Once gener-
ated, the dataset can be navigated through real-time,
with simultaneous update of the 3 orthagonal planes
in order to allow the user to identify the exact position
within the vessels. The technique used to generate CT
VIE images has been previously described in the liter-
ature.7,11 Using the fly-through software the renal
ostia were assessed for coverage by suprarenal stent
struts. The relationship of the stent struts was defined
as ‘no involvement’, ‘peripheral coverage’ and ‘cen-
tral coverage’ (Fig. 1a,b and c).
Assessment of renal function
All patients had serum creatinine values taken pre
and postoperatively and during each of the annual
CT follow-up visits as part of our routine endovascular
follow-up program. Using serum creatinine together
with physical patient data it was therefore possible
to determine renal function changes either by changes
in serum creatinine or by glomerular filtration rate
(GFR) as defined by the Cockcroft and Gault formu-
lar.15 The National Kidney Foundation guidelines on
renal dysfunction were used to classify renal dysfunc-
tion; serum creatinine levels 170 mmol/L were
considered to be indicative of renal dysfunction.16
We also considered a decline in GFR of equal to or
greater than 20% as being indicative of worsening
renal function when comparing pre-operative to latest
GFR levels; this definition was taken from the study
by Grego et al.17
Statistical analysis
The results were analysed with SPSS 11.0 for Windows
(SPSS Inc, Chicago, IL) to determine the relationship
525Bare Stent Strut and Renal Function Following EVARFig. 1. (a) CT virtual intravascular endoscopic image of a pa-
tient with no struts crossing the renal ostium. (b) CT virtual
intravascular endoscopic image of a patient with a stent
strut peripherally crossing the renal ostium. (c) CT virtual
intravascular endoscopic image of a patient with a stent
strut crossing the renal ostium in a central position.between patients with and without struts crossing the
renal ostia and renal function. Continuous data is
reported as mean values plus or minus its standard
deviation. A P value of <.05 was considered to be
statistically significant. For analysis of renal dysfunc-
tion the cohort was divided into two groups based on
renal ostial involvement by the bare suprarenal struts.
Two groups were generated; CT evidence of struts
crossing renal ostia and patients with no evidence of
involvement. Relationship between continuous vari-
ables was assessed using the student t test or Mann-
Whitney U test, relationships between categorical
variables were assessed using the Fisher exact tests.
Results
A total of fifty-five patients (51 men, mean age 73
years, range 57e90) who had endovascular repair of
their abdominal aortic aneurysms with a Talent supra-
renal stent-graft were included in the study. Demo-
graphic information is presented in Table 1. From
the Cockcroft and Gault formula15 mean GFR was
61 mL/min 18 mL/min pre-operatively for the
whole study group. There was no patient on dialysis
before the procedure, one (2%) patient had a serum
creatinine of 264 mmol/L which satisfied the National
Kidney Foundation definition of renal dysfunction.16
Mean aneurysm size for the study group was 64 mm
(range, 41e95 mm). The mean contrast volume
injected during the initial endovascular procedure
was 254 mL 74 mL. No suggestion of preoperative
renal artery stenosis was reported in the radiological
or clinical case notes in any patient.
CT VIE assessment
A total of 109 renal ostia were assessed by CT IVE
with one patient having a surgically absent kidney.
Crossing of renal ostia by bare suprarenal stent struts
occurred in 32 (29%) vessels (fifteen struts were
Table 1. Patient characteristics by coverage group
Struts crossing
No renal ostia 1 renal ostia
Total patients 28 (51%) 27 (49%)
Agea (years) 72 8 74 7
Gender/male 27 (96%) 24 (89%)
ASA Grade II 8 (29%) 8 (30%)
III 19 (68%) 15 (56%)
IV 1 (4%) 4 (14%)
Pre-Op AAA diametera (mm) 67 14 61 6
Procedural contrast
usagea (mL)
274 80 232 61
Follow-upa (months) 35  20 29  21
a Mean.
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stent struts crossed 1 renal ostium in 22 (40%) patients
and five (9%) patients had bare struts crossing both
renal arteries.
Postprocedural renal insufficency
The mean post-operative GFR was 60 mL/min
18mL/min. Ten (18%) patients had serum creatinine
levels equal or above 130 mmol/L. Three (5%)
patients were classified as having post-operative renal
dysfunction according to the National Kidney
Foundation classification system.16
Follow-up renal insufficency
The mean follow-up GFR was 57 mL/min 19 mL/
min Fifteen (27%) patients had serum creatinine levels
equal or above 130 mmol/L at latest follow-up. Conse-
quently, four (7%) patients were classified as having
follow-up renal dysfunction according to the National
Kidney Foundation (NFK) classification system.16
Three out of the four patients with NKF classified
renal dysfunction had struts crossing one renal osti-
um. Of the four patients with NKF renal dysfunction,
one patient had renal dysfunction in both the pre and
postoperative periods, the remaining three patients
first had NKF renal dysfunction classified on the
serum creatinine taken during follow-up.
Comparison of renal function and suprarenal
bare strut coverage
There were no statistically significant difference in the
change between pre-operative and latest GFR in
patients with and without struts crossing the renal ostia
(2 mL/min 9 mL/min and 6 mL/min 7 mL/min
respectively, P> 0.05; Table 2). Of the four patients
with NKF derived renal dysfunction three patients
had struts covering one renal ostium, one of these
patients had NKF renal dysfunction prior to the
EVAR procedure. There was one patient with NKF
renal dysfunction detected during follow-up without
struts covering any renal ostia. Analysis of GFR indi-
cated that there were equal numbers of patients with
and without struts crossing renal ostia who had GFR
20% during follow-up (Table 3).
Discussion
Multi-slice CT scanning is the preferred imaging mo-
dality for the follow-up of stent-grafted patients.18,19Eur J Vasc Endovasc Surg Vol 32, November 2006CT VIA is currently being investigated as a potential
addition to the post-procedural follow-up currently
being utilised today.7e13 CT VIA has been reported
has having distinct advantages in assessing renal ostia
in relation to bare suprarenal stent struts.10 The cross-
ing of renal ostia by bare stent struts occurs in 29% of
renal arteries when using the Talent stent-graft. Sun
and Zheng investigated the incidence of strut cover-
age when using the Zenith stent-graft, they reported
struts involving 90% of renal ostia.10 This incidence
of coverage with the Zenith device is higher than in
our series with the Talent (29%). This factor could be
attributed to the closer proximity and larger number
of stent struts present in the Zenith device when com-
pared to the Talent.
The investigation of renal function following endo-
vascular repair is not new. Mehta et al., compared
renal function in patients with infrarenal and
suprarenal stent-graft devices.20 They concluded that
there was no difference in renal decline when using
a transrenally fixed aortic stent-graft. However, in
a study using fenestrated stent-grafts there was a sig-
nificant risk for adverse renal events when using such
Table 2. Assessment and comparison of renal function between
coverage groups




Pre-Op SCra (mmol/L) 101 23 117 37 0.020
GFR (mLs/min) 67 17 56 17 0.020
Post-Op SCra (mmol/L) 109 26 114 31 0.341
GFR (mLs/min) 63 17 57 17 0.206
Latest SCra (mmol/L) 113 25 130 60 0.247
GFR (mLs/min) 61 18 54 19 0.144
Change e
Pre to
SCra (mmol/L) 12 17 12 36 0.319
Latest GFR (mLs/min) 6 7 2 9 0.102
a SCreserum creatinine, displayed as median values; GFRe
glomerular filtration rate, displayed as mean values.
Table 3. Assessment and comparison of classified changes in renal
function





Renal dysfunction Pre-Op 0 (0%) 1 (4%) 0.510
Post-Op 1 (4%) 1 (4%) 0.745
Latest
Follow-Up
1 (4%) 3 (11%) 0.320
GFR 20% decline Pre-Ope
Latest F/U
4 (14%) 4 (15%) 0.648
Renal dysfunction as per NKF definition16 and GFR decline accord-
ing to Grego et al.17
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studies that coverage of renal ostia by bare stent struts
does not affect renal function.7 A report by Burks
et al., concluded that transvisceral coverage by bare
stent struts occurs frequently after EVAR and is asso-
ciated with no early morbidity.22 It is generally
accepted that renal function can deteriorate following
both EVAR and open repair.23e25 This is a feature sup-
ported by data from our study, where mean GFR fell
from 61 mL/min pre-operatively to 57 mL/min at
latest follow-up.
There are numerous reports in the literature debat-
ing the use of serum creatinine levels as an indicator
of renal function. Creatinine clearance is considered
to be the gold standard for the assessment of renal
function. However, from this retrospective review,
serum creatinine was the only parameter available
to assess renal function. Therefore we opted for esti-
mated GFR using the Cockcroft and Gault formula15
which is a more superior indicator of renal function
than serum creatinine alone. A more definitive study
would require the prospective measurement of creati-
nine clearance. Data from this study uses a median
follow-up period of 24 months, the true effect of
bare struts crossing renal ostia may not become
apparent until studies with longer-term follow-up
data report. Furthermore, this study was cross-
sectional in design with data taken from a variety
of follow-up periods. This places additional limita-
tions on the study, a more ideal approach would be
to perform a baseline assessment of renal ostial cover-
age at 1-month post-treatment and then compare this
with annual follow-up scans.
The use of iodinated contrast media is controversial
in patients will elevated serum creatinine levels. In
our study there were several patients who had serum
creatinine levels >170 mmol/L. It is our policy to use
isomolar radiographic contrast in patient’s with
serum creatinine levels above 120 mmol/L and reserve
MR imaging for patient’s with serum creatinine levels
in excess of 300 mmol/L.
The location of graft fabric with respect to the renal
ostia is a variable that can potentially contribute to
changes in renal function following EVAR. In was
not our intention from this study to investigate the
distance between graft fabric and the renal ostia and
changes to renal function. This study was undertake
to outline the incidence of struts crossing renal ostia
when using the Talent stent-graft. However, we accept
that no investigating fabric coverage in addition to
strut coverage is a limitation of this study. There are
other complications associated with bare struts such
as aortic wall erosion that again have not been inves-
tigated by this study.Conclusion
Coverage of renal ostia by suprarenal stent struts from
an aortic stent-graft frequently occurs. Bare stent
struts crossing renal ostia does not affect follow-up
serum creatinine levels or glomerular filtration rates.
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